CA
DGX icon

CapWealth Advisors’s Quest Diagnostics DGX Stock Holding History

CapWealth Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-500
Closed -$27K – 366
2013
Q4 		$27K Sell
500
-72
-13% -$4.27K 0.01% 183
2013
Q3 		$35K Hold
572
– – 0.01% 181
2013
Q2 		$35K Buy
+572
New +$34.1K 0.01% 175

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
AAM
Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

CapWealth Advisors's DGX Position: Q1 2014 in Review

CapWealth Advisors sold out of Quest Diagnostics (DGX) in Q1 2014, closing a stake of 500 shares — an estimated $27K sold.

CapWealth Advisors first reported a position in DGX in Q2 2013 and held it in 3 quarters. The position peaked at $35K in Q3 2013. 491 funds tracked by Wall St. Rank hold DGX as of Q1 2014.

  • CapWealth Advisors reported no remaining Quest Diagnostics position as of Q1 2014 after selling out during the quarter.
  • CapWealth Advisors sold 500 Quest Diagnostics shares in Q1 2014, an estimated $27K.
  • CapWealth Advisors first reported a position in Quest Diagnostics in Q2 2013 and held it in 3 quarters.
  • CapWealth Advisors's Quest Diagnostics position peaked at $35K in Q3 2013.
  • 491 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2014.

Based on CapWealth Advisors's 13F filing for Q1 2014, filed 12 May 2014.